Search

everythinglearnresearchcommunity

for

Search:↓

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Finasteride may affect fetal brain development and increase arousal, but more research is needed for safety confirmation.

Chronic scalp pain in trichodynia involves both body-wide and localized increased pain sensitivity.

Woodhouse-Sakati syndrome can cause writer's cramp and other varied symptoms, highlighting the importance of genetic testing for diagnosis.

The document concludes that secondary syphilis cases are increasing and often misdiagnosed, pityriasis rubra pilaris can be distinguished from psoriasis by skin cell features, and different skin layers produce specific components during skin repair.

Oral processed egg yolk improves hair regrowth and quality in alopecia patients.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

The man's fatigue and erectile dysfunction were improved by treating his obesity-related low testosterone without needing testosterone replacement.

Hair loss can cause emotional and social issues, and various treatments, including medication, surgery, and psychological support, are needed.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Certain hormone treatments can improve acne and related conditions in women.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Hair cortisol may be a good indicator of recent mood in people with bipolar disorder.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Stress is likely causing hair loss in Formosan macaques.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Human skin can make serotonin and melatonin, which help protect and maintain it.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.